Angiopoietin-like protein 2 in psoriasis: a new linkage with metabolic syndrome

Angiopoietin-like protein 2 in psoriasis: a new linkage with metabolic syndrome

Psoriasis is a chronic disease of inflammatory nature which can be considered as a systemic disorder. Metabolic syndrome is prevalent in psoriatic patients, with a negative impact on disease severity. Angiopoietin-like protein 2 (ANGPTL2) role has been investigated in several chronic inflammatory co...

Full description

Saved in:
Bibliographic Details
Published in:Postȩpy dermatologii i alergologii Vol. 37; no. 1; pp. 86 - 91
Main Authors: Kenawy, Mohamed Zaki, Sabry, Jehan Hasan, Akl, Essam Mohamed, Emam, Noha A H
Format: Journal Article
Language:English
Published: Poland Termedia Publishing House 01-01-2020
Subjects:
Age
Blood pressure
Body mass index
Cholesterol
Chronic illnesses
Dermatology
Diabetes
Fasting
Laboratories
Medicine
Metabolic syndrome
Obesity
Original Paper
Proteins
Psoriasis
Statistical analysis
Studies
Triglycerides
metabolic syndrome
psoriasis
obesity
angiopoietin-like protein 2
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Psoriasis is a chronic disease of inflammatory nature which can be considered as a systemic disorder. Metabolic syndrome is prevalent in psoriatic patients, with a negative impact on disease severity. Angiopoietin-like protein 2 (ANGPTL2) role has been investigated in several chronic inflammatory conditions, but not in psoriasis. To evaluate the serum level of ANGPTL2 and its possible role in the occurrence of metabolic syndrome in psoriatic patients. This study enrolled 180 participants divided into two groups: psoriatic group (120 patients with chronic plaque psoriasis) and control group (60 normal subjects). Psoriasis severity was determined by the psoriasis area severity index. Anthropometric measurements, lipid profile, fasting blood sugar and ANGPTL2 have been evaluated in both groups. Psoriatic patients had a higher body mass index ( = 0.014), waist circumference ( < 0.001), and blood pressure than controls ( Ł 0.001). Fasting blood sugar and the serum level of ANGPTL2 were also higher in psoriatic patients than in controls ( < 0.001, 0.025, respectively). In addition, the serum level of ANGPTL2 was significantly correlated with both disease severity ( < 0.001) and occurrence of metabolic syndrome ( < 0.001). Serum ANGPTL2 is elevated in psoriasis patients compared to normal subjects. Serum ANGPTL2 elevation may have a role in chronic inflammatory status in psoriasis and occurrence of metabolic syndrome.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1642-395X
2299-0046
DOI:10.5114/ada.2018.79225